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Introduction
Intact epithelial-immune barriers play a critical role in maintain-
ing a physical defense between external environmental antigens 
and the internal immune system. In allergy, epithelial barriers 
are often dysfunctional, contributing to pathophysiologic mech-
anisms of atopic diseases, including atopic dermatitis, asthma, 
and eosinophilic esophagitis (EoE). Patients with EoE are likely 
to have multiple comorbid atopy and are considered part of the 
so-called atopic march (1). It is widely understood that genetic 
elements, environmental factors, and abnormal inflammatory 
or developmental signaling pathways may all contribute to the 
establishment and maintenance of a defective epithelial barrier 
in allergy, leading to increased exposure to environmental or food 
antigens, allergic sensitization, and the development of chronic 
allergic inflammatory diseases.
Clinical experience and basic studies state that these principles 
are also true in EoE, a rapidly emerging disease. Genome-wide 
association studies have identified epithelial barrier–related genes 
such as FLG and CAPN14 (2, 3). Transcriptomic studies have identi-
fied others associated with disease, including SPINK7 and SLC9A3 
(4, 5). Histologic and ultrastructural studies revealed increased 
intercellular spaces and reduced desmosomal infrastructure (6–8), 
functional studies identified increased impedance (9), and molec-
ular examinations determined key roles for inflammatory mole-
cules including the cytokine IL-13 in diminishing epithelial barrier 
(2, 4, 10). These processes are also common to other atopic disor-
ders. Pathologic epithelial remodeling responses and increased 
presence of inflammatory infiltrates and their activity are likely to 
increase the global metabolic demands on the esophageal epithe-
lium in EoE, as has been observed in other chronic diseases (11). 
To date, no study has examined the role of microenvironmental 
oxygen metabolism and hypoxia in the pathogenesis of esophageal 
epithelial barrier dysfunction in EoE.
Mucosal surfaces dynamically regulate epithelial barrier 
function despite continuous exposures to toxic, infectious, and 
allergic molecules. In order to maintain this structural interface 
with the external environment, a number of innate and endog-
enous systems exist. One vital aspect of this functionality is 
cellular metabolism and the availability of oxygen. Physiolog-
ically normal oxygen levels are unique to each tissue (“physi-
oxia”) and may be altered in response to tissue activities such 
as metabolism or disease (hypoxia; ref. 12). Evolutionary adap-
tation to a hypoxic tissue microenvironment is mediated by the 
transcription factor hypoxia-inducible factor (HIF). In several 
systems, elevated HIF has been shown to augment barrier pro-
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Results
Prolonged hypoxia leads to the suppression of HIF-1α signaling in esoph-
ageal epithelial cells. We first confirmed that esophageal epithelial 
cells were hypoxia responsive and screened a number of HIF tar-
get genes following short-term exposure to hypoxic cultures (4 and 
18 hours)(Figure 1A). Here we observed increased expression of a 
number of known target genes, including PGK1, ADM, and VEG-
FA, following a short 4-hour hypoxic culture. Interestingly, both 
GLUT1 and ENO1 were increased at 4 hours but only reached statis-
tical significance at 18 hours, suggesting there may be temporally 
distinct transcriptional regulation by HIFs in esophageal epithelial 
cells. We hypothesized that decreased HIF-1α signaling may be the 
result of prolonged hypoxic constraints on the esophageal epitheli-
um in EoE-associated inflammation and contribute to barrier dys-
tection. In this regard, we have previously established HIF’s 
roles in mucosal protective functions regulating the expression 
of epithelial trefoil factor, mucin 3, and antimicrobial defensin, 
and, more recently, HIF-1α’s regulation of tight junctions in 
T84 colon cancer cells (13–16).
In this study, we hypothesized that HIF signaling is dysregu-
lated, contributing to barrier dysfunction in the allergic esopha-
geal inflammatory disease EoE. Using in vitro and in vivo model 
systems with a recapitulation of esophageal epithelial changes in 
EoE, we sought to evaluate the potential contribution of HIF to 
the stratified squamous esophageal epithelial barrier dysfunc-
tion and investigate HIF’s potential use as a treatment modality 
focused on mucosal healing and the reestablishment of epitheli-
al barrier in allergic disease.
Figure 1. Prolonged experimental hypoxia results in attenuated HIF signaling in esophageal epithelial cells in vitro. (A) Short-term experimental 
hypoxic cultures induce elevated expression of HIF target genes. (B) HIF-1α expression was assessed by Western blot of nuclear protein lysate from 
esophageal epithelial cells exposed to a time course (0, 4, 24, 48, 72 hours) of experimental hypoxia compared with duration-matched normoxic cells 
and quantified by densitometry. (B and C) mRNA expression of HIF1A (B), HIF2A, and HIF1B (C) was assessed by real-time RT-PCR in cells exposed to a 
time course (4, 24, 48 hours) of experimental hypoxia compared with duration-matched normoxic cells. (D) Known HIF signaling target GLUT1 protein 
was assessed by Western blot in whole-cell protein lysates from esophageal epithelial cells exposed to a time course (0, 4, 24, 48, 72 hours) of exper-
imental hypoxia compared with duration-matched normoxic cells and quantified by densitometry. mRNA expression of GLUT1 was assessed by real-
time RT-PCR in cells exposed to a time course (4, 24, 48 hours) of experimental hypoxia compared with duration-matched normoxic cells. For Western 
blots, a representative actin and a set of blots for a single time course are presented. Statistical significance was assessed using Students’ t test 
comparing time point–matched normoxic controls with hypoxic samples. *P < 0.05, **P < 0.01, ***P < 0.001 (n = 3–6 per group). Data are presented as 
means ± SEM and represent a minimum of 3 experimental repeats.
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Diminished HIF-1α signaling in physioxic esophageal epithelial 
cells leads to barrier dysfunction. To assess the functional conse-
quences of diminished HIF-1α signaling in physioxic (physiolog-
ically normal oxygen) esophageal epithelial cells, we generated 
HIF1A-knockdown cells (HIF1A-KD) using shRNA technologies 
and confirmed approximately 90% protein depletion. To confirm 
the effects observed in these cells, we directly compared observa-
tions in 2 independent cell lines deficient in HIF-1α, comparing 
our generated HIF1A-KD cells with cells overexpressing a HIF1A 
that is deficient in HIF-1α transcriptional activity (HIF1A-DN). 
In a physiologically relevant, 3D air-liquid interface (ALI) model, 
barrier function in HIF1A-KD compared with shRNA control cells 
was assessed. Transepithelial electrical resistance (TEER) was 
significantly decreased (Figure 3A) and FITC flux was increased 
in HIF1A-KD cells (Figure 3A). To verify these findings, barrier and 
permeability in HIF1A-DN cells was assessed, and similar results 
were found, with increased paracellular permeability (FITC flux); 
however, the less sensitive, and differentially regulated, transcel-
lular ion transport (TEER) was decreased (15%; P = 0.3), but not 
to a statistically significant degree (Figure 3B). This may reflect 
the differential regulation of ion transport and paracellular trans-
port by HIF-1α in esophageal epithelial cells, or it could reflect the 
low sensitivity of the TEER resistance method compared with the 
paracellular FITC flux method.
Loss of basal HIF-1α signaling results in a specific decrease in clau-
din-1 expression. To test the molecular mechanisms through which 
this epithelial barrier functional deficit occurs, we performed a 
targeted array analysis of transmembrane cell-cell adhesion mol-
ecules using both HIF1A-KD and HIF1A-DN cells and focusing 
specifically on molecules concomitantly altered in both lines. We 
first noted that normal human esophageal biopsies possess the pri-
mary claudin genes CLDN1, CLDN4, and CLDN7 (Figure 3C). We 
function. We examined HIF-1α protein expression in esophageal 
epithelial cells exposed to experimental hypoxia (1% O2) compared 
with normoxic (21% O2) cultures over a sustained period. Nuclear 
HIF-1α expression was transiently and significantly elevated in cul-
tured esophageal epithelial cells (4 hours). However, this normal-
ized by 24 hours, and following sustained hypoxic culture there was 
a significant decrease in nuclear HIF-1α protein (Figure 1B). HIF1A 
mRNA expression was also decreased following prolonged hypoxia 
(Figure 1B), with no observed effect on HIF2A or HIF1B (Figure 1C). 
To confirm the downstream consequences of HIF-1α suppression 
by sustained hypoxia, the expression of the well-known HIF target 
gene GLUT1 was examined, and protein levels were not changed 
at 4 or 24 hours after hypoxia; however, coincident with decreased 
HIF-1α, by 48 hours a decrease in protein and mRNA expression, 
mirroring HIF-1α, was observed (Figure 1D).
HIF-1α signaling is attenuated in patients with ongoing active EoE. 
To understand the potential role of the transcription factor HIF-1α 
in chronic allergic esophageal inflammation, we tested whether 
expression was altered in patients with EoE. We examined protein 
and mRNA HIF-1α expression in whole esophageal biopsies from 
patients with active EoE compared with controls and patients 
with inactive EoE and found a specific decrease in comparison 
with control subjects (Figure 2A). No change in mRNA expres-
sion of HIF2A or the cotranscriptional unit HIF1B was observed in 
active EoE (Figure 2B). To examine effects of attenuated HIF-1α 
on downstream signaling, a significant decrease of the HIF tar-
get gene GLUT1 at the protein and mRNA levels was confirmed 
in active EoE subjects compared with controls and inactive EoE 
(Figure 2C). These data implicate a potential role for dysregulated 
epithelial HIF signaling in the pathogenesis of EoE, likely not in 
the initiation, and led us to investigate the functional consequenc-
es of decreased esophageal epithelial HIF-1α.
Figure 2. HIF signaling is dysregulated in patients with active EoE. Whole esophageal pinch biopsies from patients undergoing endoscopy were obtained for 
molecular analysis. (A) HIF-1α protein was assessed by mesoscale assay, and HIF1A mRNA transcript expression was assessed by real-time RT-PCR. (B) HIF2A and 
HIF1B mRNA transcript expression was assessed by real-time RT-PCR and compared between active disease, inactive disease, and control subjects. (C) Known 
HIF signaling pathway target GLUT1 protein was assessed by Western blot and quantified by densitometry, and mRNA transcript expression was assessed by 
real-time RT-PCR and also compared between active disease, control subjects, and those with inactive disease. Statistical significance was assessed using the 
nonparametric Kruskal-Wallis test with Dunn’s correction for multiple comparisons. *P < 0.05, **P < 0.01, and ***P < 0.001 (mean ± SEM, n = 5–10 per group).
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on CLDN1 expression in esophageal epithelial cell cultures. A sig-
nificant decrease in the expression of claudin-1 protein in cells in 
sustained hypoxia compared with time point–matched normoxic 
controls was detected, and this was confirmed by mRNA (Figure 
3F). Together, these data support the distinguishing hypothesis 
that prolonged or sustained hypoxia in the esophageal epithelium 
leads to suppressed HIF-1α and decreased claudin-1 expression, 
and we suggest that this may occur in part through the dysregula-
tion of HIF-1α–mediated CLDN1 expression and that it underlies 
the development of barrier dysfunction in EoE pathogenesis.
ChIP analysis confirmed CLDN1 as a direct HIF-1α target gene in 
stratified squamous esophageal epithelia. We next examined wheth-
er CLDN1 was a direct HIF-1α target gene in esophageal epithelial 
cells. First using chromatin immunoprecipitation (ChIP), we exam-
ined HIF-1α’s capacity to bind to the CLDN1 gene promoter. We 
identified 2 hypoxia-responsive elements (HREs) 224 bp and 588 bp 
upstream of the CLDN1 transcription start site. We observed signif-
next assessed their mRNA expression in HIF1A-KD and HIF1A-
DN cells cultured at ALI and observed a significant and selective 
decrease in the tight junction molecule CLDN1 (Figure 3D). We 
confirmed this specific claudin-1 effect at the protein level in both 
cell lines targeted for HIF-1α suppression (Figure 3E). In addition, 
we confirmed the CLDN1-specific decrease in HIF1A-KD epithe-
lial cells grown in independent submerged cultures (CLDN1, 56% 
decrease, P < 0.01; CLDN4 and CLDN7, NS). Significant changes 
in desmoglein and cadherin molecules were observed in HIF1A-
KD cells that were not observed in HIF1A-DN cells, and thus were 
not pursued further in these studies. Together these data suggest 
that basal HIF-1α expression is integral to esophageal barrier func-
tion and mediates it in part by controlling claudin-1 expression.
Prolonged hypoxia leads to decreased CLDN1 expression in esoph-
ageal epithelial cells. Given the suppression of HIF-1α signaling in 
the context of prolonged hypoxia and the relationship between 
HIF-1α and CLDN1, we assessed the effects of prolonged hypoxia 
Figure 3. HIF-1α attenuation mediates esophageal epithelial barrier dysfunction and diminishes claudin-1 expression.  (A and B) Esophageal epithelial cell 
lines were generated by shRNA-mediated HIF-1α suppression (HIF1A-KD) (A) and overexpression of a transcriptionally inactive dominant-negative HIF-1α variant 
(HIF1A-DN) (B). These cells and respective controls (scrambled shRNA [shCtrl] or empty vector [evCtrl]) were grown at ALI, and epithelial barrier (TEER) (n = 3) 
and paracellular permeability (3-kDa FITC-dextran flux) were measured in vitro (n = 5–7). (C) Patients’ endoscopic esophageal pinch biopsies were assessed for 
mRNA expression of an array of claudin genes (n = 10). (D) HIF1A-KD and HIF1A-DN cells were examined for the expression of transmembrane junctional mole-
cules. The dashed line represents control cells normalized to 1-fold. Heatmaps generated from normalized data (n = 3). (E) Western blotting confirmed claudin-1 
protein loss in HIF1A-KD and HIF1A-DN cells, quantified by densitometry (n = 3). (F) Esophageal epithelial cells exposed to a time course (4, 24, 48, 72 hours) of 
experimental hypoxia compared with duration-matched normoxic cells were assessed for claudin-1 protein by Western blot in whole-cell lysates, and CLDN1 
mRNA by real-time RT-PCR (n = 3–6). Statistical significance was assessed using Students’ t test. *P < 0.05, **P < 0.01. Data are expressed as means ± SEM 
and represent a minimum of 3 experiments.
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lamina propria (ref. 17 and Figure 5A). Colocalization of Hypoxy-
probe-1+ hypoxic tissue staining with eosinophilia (Siglec-F) in the 
esophageal epithelium in L2-IL5OXA EoE mice was evident (Figure 
5A). In vitro activated human eosinophils were capable of rapidly 
consuming oxygen (pO2 measurements) from their local microen-
vironment when compared with nonactivated eosinophils (Figure 
5A). To assess the effects of eosinophilic inflammation on tissue 
hypoxia in L2-IL5OXA EoE mice, we measured the area of Hypoxy-
probe-1+ esophageal tissue. We elucidated a significant increase in 
the esophageal epithelium under hypoxic constraints compared 
with uninflamed WTOXA controls (Figure 5B). These findings impli-
cate activated eosinophils and their chronic esophageal epithelial 
infiltration in the sustained hypoxic burden on the esophageal epi-
thelium during EoE.
Consistent with in vitro (Figure 1) and human subject (Figure 
2) data, a significant decrease in HIF-1α signaling was observed in 
the L2-IL5OXA EoE mouse. Western blotting confirmed decreased 
HIF-1α protein and attenuated HIF activity using ODD-LUC 
HIF-reporter-L2-IL5OXA EoE mice compared with controls (ODD-
LUC HIF-reporter-WTOXA). Congruent with active clinical EoE 
specimens, decreased HIF1A mRNA and downstream signaling 
through the known HIF target gene GLUT1 were confirmed (Fig-
ure 5C). The L2-IL5OXA EoE mice exhibited elevated histologic 
activity, including significant intraepithelial eosinophilic inflam-
mation, dilated intracellular spaces, and basal cell hyperplasia 
(Figure 5D). Consistent with clinical EoE, a significant decrease in 
EoE mouse esophageal CLDN1 mRNA and protein was observed 
(Figure 5E). These data support our hypothesis that the HIF-1α/
icant enrichment for HIF-1α binding to the most proximal HRE1–224 
(Figure 4A). We tested the specificity of this response by con-
structing HRE site mutants and assessing CLDN1-LUC promoter 
reporter construct activation. Consistent with the importance of 
the HRE1 site in ChIP, CLDN1-LUC expression was significantly 
decreased in the HRE1 site mutant (Figure 4A). These data con-
firm the importance of direct HIF-1α transcriptional activation of 
CLDN1, specifically through the CLDN1 promoter HRE1 site.
CLDN1 expression is attenuated and claudin-1 protein is mislo-
calized in patients with EoE. To determine the clinical relevance of 
these findings, we measured HIF-1α/claudin-1 in human esoph-
ageal biopsies. CLDN1 mRNA was significantly decreased in 
active EoE compared with those with inactive disease and normal 
controls (Figure 4B). Immunohistochemical staining identified 
changes in claudin-1 protein pattern in comparison with normal 
tissues. Instead of the typical “chicken wire,” membrane pattern, 
EoE tissues were found to have decreased cell membrane expres-
sion (Figure 4C) that corresponded to areas of dilated intercellular 
spaces observed in H&E-stained tissues (Figure 4D).
Prolonged and sustained hypoxia mediated by chronic esophageal 
epithelial eosinophilia leads to dysregulated HIF-1α/CLDN1 signaling 
axis in an experimental mouse model of EoE. We next hypothesized 
that one contributor to esophageal hypoxia during EoE-associat-
ed inflammation were eosinophils themselves. We developed a 
mouse model of EoE (L2-IL5OXA) that results in significant esoph-
ageal eosinophilia, and by using major basic protein (MBP) immu-
nohistochemistry we could identify eosinophils located through-
out and intimately in contact with the epithelium, in addition to 
Figure 4. CLDN1 is a direct HIF-1α target gene, and 
claudin-1 protein is mislocalized in active EoE 
patients. (A) Proximal human CLDN1 promoter 
sequence identified 2 potential hypoxia-responsive 
elements (HREs). Transcription start site, +1. ChIP 
using a HIF-1α antibody on cells exposed to 4 hours 
of hypoxia compared with normoxia, followed by 
PCR using primers spanning HRE2 and HRE1 sites, 
was normalized to PCRs performed on ChIP product 
generated using an isotype IgG control antibody (n 
= 3). Luciferase activity in lysates transfected with 
full-length CLDN1 promoter (WT) compared with 
cells transfected with either mutated HRE site 1 or 
mutated HRE site 2. Luciferase data normalized to 
total cell protein content (n = 6). Statistical signifi-
cance was assessed using an ordinary 1-way ANOVA 
with correction for multiple comparisons. *P < 0.05, 
**P < 0.01. (B) Esophageal pinch biopsies from patients 
undergoing endoscopy were obtained and assessed 
for CLDN1 expression by real-time RT-PCR (n = 6–10 
per group). Statistical significance was assessed 
using the nonparametric Kruskal-Wallis test with 
correction for multiple comparisons. *P < 0.05, **P < 
0.01. (C) Representative photomicrographs of claudin-1 
immunolocalization. Scale bars: 100 μm. (D) Arrows 
depict dilated intercellular spaces in H&E-stained FFPE 
pinch biopsies from active EoE subjects compared with 
normal controls. Data are expressed as means ± SEM 
and represent a minimum of 3 experimental repeats.
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claudin-1 axis is dysregulated in EoE in response to chronic esoph-
ageal inflammation, and support the utility of the L2-IL5OXA EoE 
mouse in examining mechanisms of barrier dysfunction.
Conditional HIF-1α overexpression is protective in an EoE mouse 
model, and pharmacologic stabilization in human biopsies restores the 
HIF-1α/CLDN1 axis. Based on these findings, we speculated that 
HIF-1α stabilization might serve as a novel therapeutic intervention 
for EoE barrier dysfunction. To begin to address this, the L2-IL5OXA 
mouse EoE model was genetically modified to selectively overex-
press HIF-1α in the esophageal epithelium. Here, mutated, non–oxy-
gen-sensitive, and thus less degradable HIF-1α was overexpressed 
specifically in the esophageal epithelium using the cytokeratin/
K14 promoter, crossed with the L2-IL5 mouse (K14Cre/LSL-HIF1A-
dPA/L2-IL5). K14Cre/LSL-HIF1A-dPA/L2-IL5OXA mice experienced 
significantly attenuated epithelial histologic activity scores and 
eosinophilic inflammation compared with inflamed K14Cre-neg-
ative (K14Cre–) EoE controls (Figure 6A). Furthermore, claudin-1 
protein and mRNA were significantly increased in comparison with 
inflamed K14Cre– EoE controls (Figure 6B). Confirming that this 
was associated with HIF-1α activity, increased expression of HIF 
target genes was observed in both K14Cre+ non–OXA-challenged 
and K14Cre+ OXA-challenged mice compared with K14Cre– con-
trols (Table 1). Taking a pharmacologic approach in vitro, the pan- 
hydroxylase inhibitor dimethyloxalylglycine (DMOG) was used 
to stabilize HIF. Consistent with reports in other cells, esophageal 
epithelial cells exposed to DMOG showed increased GLUT1 and 
Figure 5. Prolonged and sustained hypoxia mediated by esophageal eosinophilia in experimental EoE leads to a dysregulated HIF-1α/CLDN1 signaling axis. 
(A) L2-IL5 transgenic mice and WT littermate controls were exposed to OXA-induced esophagitis and assessed for esophageal eosinophils using MBP immuno-
histochemistry or immunofluorescence for Siglec-F in conjunction with Hypoxyprobe-1 (Hx-1) (n = 3–9). Eosinophils were enumerated based on MBP staining per 
high-power field (HPF). Primary peripheral blood human eosinophils were isolated and stimulated in the presence or absence of PMA and assessed for oxygen 
consumption over time (minutes) (n = 3). Scale bars: 20 μm. (B) L2-IL5 transgenic mice and WT littermate controls were exposed to OXA-induced esophagitis 
and assessed for tissue oxygen tension by Hypoxyprobe-1 (Hx-1) immunofluorescent staining, which was quantified to measure the area of tissue under hypoxic 
constraints (n = 9 per group). Scale bars: 50 μm. (C) Whole esophageal tissues from OXA-challenged L2-IL5 and WT littermate control mice were assessed for 
HIF-1α protein expression by Western blot and quantified by densitometry (n = 4–6). WT ODD-LUC and L2-IL5/ODD-LUC luciferase reporter mice were challenged 
with OXA-induced esophagitis and assessed by luciferase assay for HIF/luciferase activity relative to total tissue protein (n = 12). OXA-challenged L2-IL5 and WT 
littermate control mice were assessed for HIF1A and GLUT1 mRNA expression by real-time RT-PCR (n = 5). (D) OXA-challenged L2-IL5 and WT littermate control 
mice were assessed for histologic activity scores from H&E-stained esophageal tissues (n = 8–9). Scale bars: 50 μm (top); 20 μm (bottom). (E) Whole esophageal 
tissues were assessed for claudin-1 protein by Western blot and quantified by densitometry (n = 11), and were assessed for CLDN1 mRNA transcript expression 
by real-time RT-PCR (n = 5). Representative blot is presented. Statistical significance was assessed using Students’ t test. *P < 0.05, **P < 0.01, ***P < 0.001. 
Data are expressed as means ± SEM and represent a minimum of 3 experimental repeats.
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CLDN1 expression at 4 and 18 hours (Figure 6C). To test clinical 
applicability, human esophageal biopsies were treated with DMOG 
ex vivo. Tissue biopsies from both controls and active EoE subjects 
treated ex vivo with DMOG showed significantly increased expres-
sion of GLUT1 and CLDN1 (Figure 6D). Cumulatively, these data 
support the pursuit of HIF-1α–stabilizing therapies in addressing 
barrier dysfunction in EoE.
Discussion
In this study we report the striking decrease in esophageal expres-
sion of the transcription factor HIF-1α and its direct role in barrier 
dysfunction as a potentially novel pathophysiologic mechanism 
in the chronic allergic disease eosinophilic esophagitis (EoE). We 
demonstrate increased oxygen demands placed on the epithelial 
surface by eosinophilic inflammation and how chronic hypoxia 
contributes to maladaptive epithelial responses. Previous studies 
examining endogenous protective mechanisms of mucosal sur-
faces demonstrated a protective role for HIF-1α, a critical tran-
scription factor in the adaptation to low oxygen tension (14–16). 
This study adds HIF-1α–focused therapies to the list of candidate 
treatments derived from endogenous protective mechanisms and 
directed at the maintenance and restoration of esophageal epithe-
lial barrier and, furthermore, provides the foundation for exten-
sive testing in other atopic conditions.
Previous work indicated, counter to expectations, that 
decreased HIF-1α is a result of prolonged experimental hypoxia 
in epidermal keratinocytes, endothelial cells, lung adenocarcino-
ma, and colon cancer cell lines in vitro (18–21). As observed in our 
control cells, nuclear HIF-1α may be augmented by the increas-
ing confluence of cells in culture (22), and indeed this regulation 
may be cyclical, allowed for by nuclear-cytoplasmic shuttling (23). 
This regulation has been attributed to the actions of both prolyl 
hydroxylase–mediated protein degradation and microRNA-me-
diated mRNA degradation. Here we showed that while short cul-
tures could induce nuclear HIF-1α accumulation and target gene 
expression, prolonged hypoxia in vitro resulted in esophageal 
Figure 6. Genetic and pharmacologic stabilization of esophageal epithelial HIF-1α attenuates inflammation and barrier dysfunction in a mouse 
model of EoE via claudin-1 restoration. (A) Triple-transgenic L2-IL5+/LSL-HIF1A-dPA+/+/K14Cre+ and Cre– control mice were exposed to OXA-induced esoph-
agitis (n = 5–21) and assessed for histologic activity scores from H&E-stained tissues. Esophageal eosinophils were assessed using MBP immunohistochem-
istry and enumerated by MBP+ staining per HPF. Representative H&E photomicrographs. Scale bars: 20 μm. (B) Mice were assessed for claudin-1 protein by 
Western blot, quantified by densitometry, and CLDN1 mRNA by real-time RT-PCR. (C) GLUT1 and CLDN1 mRNA were assessed by real-time RT-PCR in cells 
exposed to DMOG (1 mM) over a time course (4, 18 hours) (n = 6). (D) Patients’ endoscopic esophageal pinch biopsies were obtained and treated ex vivo with 
DMOG (500 μM) for 24 hours. Biopsies were harvested and assessed for GLUT1 and CLDN1 mRNA by real-time RT-PCR (n = 6). Statistical significance was 
assessed using Students’ t test. *P < 0.05, **P < 0.01, ***P < 0.001. Data are expressed as means ± SEM and represent a minimum of 3 experiments.
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leading to invasion (33). Although previous studies described 
the esophageal expression of claudins 1, 4, and 7 (33), no pre-
vious assessment examined a larger panel of transmembrane 
junctional molecules in the healthy esophagus. In this screen of 
23 claudin isoforms in the healthy human esophagus, we found 
claudins 1, 4, and 7 to be the most highly expressed. Further-
more, in 2 HIF-1α–deficient cell lines used in these studies, we 
found a specific and selective, structural and functional, rela-
tionship between HIF-1α and transcriptional regulation of clau-
din-1 not observed in any other junctions, adherens junctions, or 
desmosome members. Notably, no increase in other tight junc-
tion claudins (claudin-4 or -7), occludin, or zonula occludens-1 
was observed in either HIF1A-KD or HIF1A-DN cells, despite this 
claudin-1–specific decrease. It is well appreciated that the regu-
lation and interdependency or coregulation of the large family 
of claudin molecules is a diverse, complex, and often redundant 
process that is cell type and organ specific during development 
and homeostasis, in addition to the responses to microenviron-
mental cues such as inflammation or indeed hypoxia (34, 35). 
We cannot exclude in totality potential indirect effects of CLDN1 
suppression itself on other junctional molecules; however, our 
data support the utility of genetically and pharmacologically 
targeting HIF-1α to mediate attenuated esophageal inflamma-
tion in conjunction with increased claudin-1 expression in both 
mouse and human studies. We previously reported a decrease in 
esophageal claudin-7 in EoE patients in response to TGF-β1 (36). 
We demonstrate here that decreased claudin-7 is not mediated 
by HIF-1α; however, together these studies now propose mul-
tiple and independent pathophysiologic mechanisms uniquely 
targeting each of 2 tight junction claudins in EoE. Accordingly, 
the HIF-1α isoform appears to play a key selective role in esoph-
ageal barrier function by mediating the expression of CLDN1, 
and both are decreased in active human EoE and the L2-IL5OXA 
EoE mouse model. Given the fundamental importance of bar-
rier in atopy, our findings presented in these studies also have 
implications in the broader field of atopic diseases.
It is well recognized that the healthy skin is hypoxic (37) and 
that HIF-1α signaling is important for wound revascularization, 
cellular migration, and wound closure (38, 39). In contrast, HIF-2α 
signaling can delay skin wound healing (40), suggesting opposing 
roles for these 2 isoforms in the skin. HIF-1α signaling is favorable 
for keloid-derived keratinocyte epithelial-mesenchymal transi-
tion (41) and epidermal carcinogenesis (42). Hypoxia can enhance 
proliferation and migration of skin outer root sheath cells (43). 
Other esophageal studies have characterized HIF-1α and HIF-2α 
expression as prognostic biomarkers in GERD (44) and progres-
sion of Barrett’s esophagus to esophageal adenocarcinoma (45), 
while increased HIF-2α is thought to participate in mediating 
inflammation in GERD (44). This study focuses on the chron-
ic allergic esophageal disease EoE and is, to our knowledge, the 
first study using a staining approach to show that, like the normal 
skin, the physiologically healthy esophagus is hypoxic. Decreased 
HIF1A mRNA expression has recently been associated with food 
impactions in EoE patients during a transcriptomics study (46). 
To our knowledge, ours is the first study to mechanistically dissect 
the role of HIF-1α in esophageal epithelial function and in the con-
text of mucosal healing in EoE.
epithelial suppression of HIF-1α. We report a specific repression 
of the HIF-1α transcription factor distinct from any effects on 
HIF2A or HIF1B during sustained tissue hypoxia in the esophageal 
epithelium in both mouse and human studies. Notably, while we 
observed increased transcription of the HIF target gene GLUT1, 
no concomitant increase in GLUT1 protein was observed. The 
regulation of GLUT1 mRNA and protein is a complex process 
involving posttranslational and post-transcriptional events, and 
similar mRNA increases in the absence of protein have previously 
been reported (24, 25). Future detailed and focused studies may 
examine the regulation of GLUT1 expression at these levels and, in 
addition, glucose affinity, membrane density, and distribution rel-
ative to protein half-life in esophageal epithelial cells. Eosinophil 
activation rapidly increased oxygen consumption consistent with 
neutrophils (26), suggesting that sustained esophageal infiltration 
of activated eosinophils would in part contribute to increased tis-
sue oxygen demands. Supporting clinical relevance was demon-
strated through decreased esophageal HIF-1α signaling in EoE 
patient specimens and confirmed by a concurrent decrease in the 
canonical HIF target gene GLUT1 (27). The prolonged nature of 
the elevated hypoxia affecting the esophageal epithelium in EoE 
is supported by the finding that activated eosinophils consume 
oxygen from the local epithelial microenvironment and thus may 
contribute to long-lasting tonal increases in esophageal epithelial 
hypoxia, mediating HIF-1α suppression.
Tight junctions, adherens junctions, and desmosomes are 
crucial cell-cell junctions that support tissue integrity. Para-
cellular macromolecule movement and barrier function are 
mediated in part by the tissue-specific transmembrane claudin 
protein family. Their altered expression and cellular redistribu-
tion are key steps in certain pathophysiologies, and claudins are 
elegantly regulated and expressed in a tissue- and cell type–spe-
cific manner (28). Claudin-1 is a critical mediator of skin barrier 
(29). In the esophagus, claudin-1 is decreased in gastroesopha-
geal reflux disease (GERD) (30) and EoE (31), is associated with 
increased spongiosis (32), and in one study was described as 
nonresponsive to corticosteroid therapy (8). In esophageal squa-
mous cell carcinoma, claudins 1, 4, and 7 are also dysregulated, 
Table 1. L2-IL5+/LSL-HIF1A-dPA+/+/K14Cre+ mice at baseline 
(Control) and during esophagitis (L2-IL5OXA) compared relative to 
baseline Cre– controls or vehicle-challenged (n = 5–6 per group)
Control





Fold change Cre– Ctrl Cre+ dPA
GLUT1 1 1.45A
PGK1 1 1.72 (P = 0.08)
ADM 1 1.89B
AP < 0.05, BP < 0.01, CP < 0.001.
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of the clinical record, subjects were subdivided into normal controls, 
EoE-active, and EoE-inactive. Subjects were defined as follows: (a) 
Control subjects had symptoms including abdominal pain, feeding 
difficulty, poor weight gain, and diarrhea, were not found to have 
an underlying clinical cause, and had normal esophageal histology 
including 0 eosinophils per high-power field (HPF). (b) EoE-active 
subjects had symptoms of esophageal dysfunction including abdom-
inal pain, dysphagia, feeding difficulty, poor weight gain, and vom-
iting and ≥15 eosinophils per HPF, and other causes for eosinophilia 
had been ruled out according to consensus recommendations (49). (c) 
EoE-inactive subjects had an established EoE diagnosis and under-
went treatment with topical corticosteroids or dietary elimination 
with resolution of symptoms and fewer than 15 eosinophils per HPF. 
Clinical features recorded included clinicopathologic diagnosis, age, 
sex, and peak eosinophils per HPF (Table 2). Esophageal biopsies were 
either placed in 10% buffered formalin for paraffin embedding, sec-
tioning, and H&E analysis or another set of biopsies were snap-frozen 
and stored at –80°C for molecular analysis as described. For ex vivo 
cultures, biopsies were placed in media containing the pan-hydroxy-
lase inhibitor dimethyloxalylglycine (DMOG; 500 μM) for 24 hours 
and harvested for mRNA analysis.
Cell culture and 3D ALI culture. EPC2-hTERT, EPC2-hTERT-HIF-
1αDN (DNA-binding domain deleted), and EPC2-hTERT-ev control 
immortalized human esophageal epithelial cells were generated and 
cultured routinely in keratinocyte serum-free media (KSFM; Thermo 
Fisher Scientific) as previously described (36, 50, 51).
Cellular responses to experimental hypoxia and to the pan-hy-
droxylase inhibitor (DMOG, 1 mM; Cayman Chemical) were assessed 
for mRNA (24-well) and protein (6-well) analysis. Twenty-four hours 
after plating, medium was replaced with preconditioned normox-
ic (21% O2) or hypoxic (1% O2) medium or with medium containing 
DMOG, and cells were placed in respective culture chambers for 0, 4, 
18, 24, 48, or 72 hours for analysis.
For assessment of barrier and ChIP, cells were grown in a 3D 
air-liquid interface (ALI) culture system, previously described (7, 36). 
Briefly, cells were seeded onto 0.4-μm-pore-size polyester 6-well 
Transwell supports and grown to confluence (Corning Costar). Cells 
were placed in high-calcium KSFM ([Ca2+] = 1.8 mM) and cultured for 
5 days at ALI to allow barrier to form. At this point cells were assessed 
for barrier function or harvested for mRNA, protein, or ChIP analysis. 
Barrier assessment was performed by 2 means, first using transepi-
thelial electrical resistance (TEER) with an ohm meter (World Pre-
cision Instruments), and second assessing paracellular permeability 
using the highly sensitive 3-kDa FITC-dextran (3 kDa; Molecular 
Probes, Invitrogen) flux assays previously described (36). Cells were 
harvested in RLT buffer from Qiagen RNeasy kits for mRNA, RIPA 
buffer plus Roche cOmplete Mini Protease Inhibitor Cocktail (Sig-
ma-Aldrich) for protein or for ChIP.
Chromatin immunoprecipitation. For ChIP, cells were exposed to 
normoxia or hypoxia for 5 hours and fixed in 1% formaldehyde for 10 
minutes at 4°C. Cells were sonicated, and the resulting sheared chro-
matin was incubated with 5 μg of control goat IgG or goat anti–human 
HIF-1α antibody (NB100-134, Novus Biologicals) and ChIP performed 
per the manufacturer’s instructions (Exacta-ChIP Kit, R&D Systems). 
Input DNA, beads, IgG, and DNA replicates enriched for HIF-1α bind-
ing were amplified by real-time reverse transcriptase PCR (RT-PCR) 
using CLDN1 promoter HRE-spanning primers (Table 3).
With the exception of topical barrier creams/emulsions in 
atopic dermatitis, no current atopic disease therapy directly targets 
the mucosa for endogenous healing mechanisms and epithelial 
barrier restoration. Current therapies for EoE are limited to dietary 
exclusion of food allergens, swallowed topical steroids, or endo-
scopic dilation, each of which can impact quality of life, involve 
poor adherence/compliance, and have potential side effects (47). 
An important recent study highlighted the continued absence of 
junctional proteins in patients with EoE despite corticosteroid 
treatment being effective in reducing innate immune mechanisms 
(8). Thus, a therapy focused on augmenting barrier, and possibly 
independent of immune effects, would be of significant impor-
tance for EoE. In order to address the need for alternative thera-
peutic options, we sought to understand the potential role for the 
transcription factor HIF-1α in esophageal epithelial mucosal heal-
ing and barrier. In these studies we identified a specific decrease 
in esophageal HIF-1α expression in EoE, while, interestingly, 
HIF-2α remained unchanged. Thus, these studies have elucidated 
unique epithelial cell responses to esophageal inflammation in a 
disease context–dependent manner and support the development 
of HIF-1α– specific targeting therapies for EoE.
In these studies, the HIF-stabilizing pan-PHD inhibitor DMOG 
was used, which may mediate effects on all isoforms. Reinforcing 
the translational relevance, we observed increased claudin-1 expres-
sion in vitro in epithelial cells and ex vivo in human explant biopsy 
tissues cultured with DMOG. In support of these findings, previous 
functional studies with colon adenocarcinoma cells found that PHD 
inhibition decreased IFN-γ–induced barrier dysfunction (48). Com-
plications related to systemic PHD inhibition involving multicellular 
effects, including circulating eosinophils, and difficulty in obtaining 
HIF-1α–selective compounds, led to the development of a selective 
genetic approach in vivo to generate a Cre-flox transgenic mouse 
that overexpressed HIF-1α in the esophageal epithelium. Having 
overcome HIF isoform and epithelial cell specificity, we uncovered 
a striking and significant attenuation of inflammation and the res-
toration of claudin-1 expression in EoE mice. Thus, we can conclude 
that epithelial-specific attenuation of claudin-1 by HIF-1α contrib-
utes to inflammation, highlighting the need for future studies focus-
ing on localized delivery of innovative HIF-1α–specific therapeutics.
In conclusion, we believe these studies establish a novel and 
crucial role for the hypoxia-associated transcription factor HIF-
1α in the regulation of stratified squamous epithelial responses 
during allergic esophageal inflammation. Eosinophil infiltration 
into the physioxic esophagus leads to a sustained increase in oxy-
gen consumption, tissue hypoxia, HIF-1α suppression, decreased 
claudin-1, and barrier disruption. Using genetic and pharmacolog-
ic approaches, these studies provide a mechanistic explanation for 
the beneficial effects of the restoration of oxygen-metabolism sig-
naling and highlight an innovative therapeutic modality for selec-
tive HIF-1α targeting as a useful mechanism to restore epithelial 
barrier and in mucosal healing for patients with allergic esopha-
geal inflammation and EoE.
Methods
Human subjects. Subjects aged 2–20 years from Children’s Hospital 
Colorado who underwent clinically indicated endoscopy and esoph-
ageal mucosal biopsy were included in these studies. Based on review 
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assessed after culture in the presence or absence of 1 μM PMA (Sig-
ma-Aldrich) for the 80-minute duration of the O2 consumption assay. 
Real-time O2 measurements were performed using Oxodish plates on 
an SDR reader (PreSens; ref. 26).
Mice. Studies were performed with male and female transgenic 
L2-IL5 mice (17) bred in house (C57BL/6J; Jackson 000664). ODD-
LUC FVB.129S6-Gt(ROSA)26Sortm2(HIF1A/luc)Kael/J (ref. 52; Jackson 
006206), K14-Cre Tg(KRT14-cre)1Amc/J (Jackson 004782), and 
LSL-HIF1A-dPA B6.129S6(C)-Gt(ROSA)26Sortm3(HIF1A*)Kael/J (Jackson 
009673) mice were obtained from The Jackson Laboratory. L2-IL5/
ODD-LUC double-transgenic mice were generated by crossing of 
ODD-LUC with L2-IL5 mice. L2-IL5–negative ODD-LUC mice were 
controls. Triple-transgenic mice were generated by crossing of K14-
Cre mice with LSL-HIF1A-dPA mice and L2-IL5 mice (L2-IL5+/HIF-
1α-dPA+/+/K14Cre+). Cre-negative littermates were controls. Animals 
were maintained in microisolator specific pathogen–free housing at 
the University of Colorado. Age- and sex-matched littermate mice 
were experimental controls.
Induction of experimental EoE in L2-IL5OXA mice using OXA. Induc-
tion of esophageal eosinophilia in mice carrying the L2-IL5 trans-
gene (L2-IL5OXA EoE) was established as previously described using 
a 4-ethoxymethylene-2-phenyl-2-oxazolin-5-one (oxazolone [OXA], 
Sigma-Aldrich) contact hypersensitivity protocol (17). Briefly, anes-
thetized mouse abdomens were shaved, and OXA was applied (3% 
[wt/vol] in 4:1 acetone/olive oil vehicle). Mice were challenged by 
an intraesophageal gavage of 2% (wt/vol) OXA in 30% ethanol/
olive oil vehicle on days 5, 8, and 12. In some studies, 200 mg dexa-
methasone was administered on protocol days 5, 8, 10, and 12 by i.p. 
injection (Vedco; ref. 17). All mice were assessed 24 hours after the 
last challenge (protocol day 13), and esophagi were removed and pro-
cessed. ODD-LUC mouse (52) esophageal tissues were sonicated and 
assessed for firefly luciferase activity using standard Dual Luciferase 
Assay Kit (Promega), with data standardized to total protein.
Immunofluorescence and immunohistochemical analysis. Patient 
mucosal pinch biopsies or whole-length mouse esophageal tissues 
were fixed with 10% neutral buffered formalin, processed, par-
affin-embedded, cut into 5-μm sections, and either stained with 
H&E (Sigma-Aldrich) or subjected to immunohistochemistry for 
eosinophil major basic protein-1 (MBP-1; clone MT-14.7, Lee Labs, 
Mayo Clinic, Arizona, USA; refs. 17, 53) or immunofluorescence for 
human claudin-1 (polyclonal rabbit anti–claudin-1; 51-9000, Invi-
trogen) with appropriate Alexa Fluor (Invitrogen) secondary anti-
body, mouse Hypoxyprobe-1 (mouse FITC-Mab or mouse Dylight 
549-Mab) (Hypoxyprobe Inc.), and mouse PE-labeled Siglec-F (BD 
Biosciences). MBP-1 was visualized with Permanent Red chemo-
trope (Dako) and counterstained with Methyl Green (Vector Labora-
tories). Immunofluorescence slides were counterstained with DAPI 
(Invitrogen). Quantification of MBP-1–immunopositive cells or Hyp-
oxyprobe-1–positive tissue area was determined by gathering of the 
shRNA knockdown, promoter mutagenesis, transfections, and lucif-
erase assay. For HIF1A knockdown in EPC2-hTERT cells, cells were 
transduced with HIF1A-targeting shRNAs incorporated into lentiviral 
particles (MISSION TRC shRNA, Sigma-Aldrich) for 24 hours before 
0.3 μg/mL puromycin antibiotic selection. Nontargeting shRNA was 
used as a control (shCtrl). Knockdown was confirmed by Western blot 
analysis, indicating approximately 90% depletion of HIF1A.
CLDN1 promoter luciferase reporter construct (Switchgear 
Genomics) was mutated using the QuikChange Site-Directed Muta-
genesis Kit previously described (ref. 13; Agilent) with primers direct-
ed against each HRE site (Figure 4A). Four hundred nanograms of the 
luciferase reporter plasmids CLDN1-WT-Luc, CLDN1-δHRE1-Luc, 
and CLDN1-δHRE2-Luc were transfected in 24-well dishes using 
Fugene reagent (Promega) per the manufacturer’s instructions. Cells 
were harvested 48 hours after transfection and promoter luciferase 
activity measured using Lightswitch luciferase reagent (Switchgear 
Genomics) and normalized to total cell protein determined using 
Pierce BCA assay (Thermo Fisher Scientific).
Human eosinophil isolation. Human eosinophils were isolated from 
healthy volunteers. Briefly, white blood cells were isolated from whole 
blood and anticoagulated with 5% citrate buffer. Plasma was removed 
following centrifugation. Erythrocytes were pelleted from leukocytes 
using 6% dextran/0.9% saline sedimentation (Fluka). Granulocytes 
were isolated from discontinuous Percoll gradients (42% and 51%; 
Sigma-Aldrich) and monocytes discarded. Residual erythrocytes were 
lysed with ice-cold water, and the remaining cells washed. Eosinophils 
were purified by negative selection using anti-CD16 and anti-CD14 
MACS microbeads and AutoMACS separation (Miltenyi Biotec). 
Eosinophils were more than 95% pure as assessed by 4% fast green. 
Freshly isolated eosinophils were cultured in 25 ng/mL IL-5 and 
Table 3. ChIP PCR primers




Table 2. Patient demographics examined in RT-PCR, Mesoscale 
assay (MSD), Western blot, or DMOG ex vivo cultures
Biopsy set 1: RT-PCR (Ctrl = 10, EoE-active = 10, EoE-inactive = 6)
Age Male Female Peak eosinophils per high-power field
Ctrl 8.2 ± 1.3 50% 50% 0 ± 0
EoE-active 8.9 ± 1.7 60% 40% 46.5 ± 11
EoE-inactive 7.16 ± 1.6 33.3% 66.6% 2.16 ± 1.10
Biopsy set 2: MSD (Ctrl = 10, EoE-active = 8, EoE-inactive = 9)
Age Male Female Peak eosinophils per high-power field
Ctrl 11.4 ± 1.3 60% 40% 0 ± 0
EoE-active 9.5 ± 2 50% 50% 61.75 ± 11.5
EoE-inactive 7.1 ± 0.8 33.3% 66.6% 1.89 ± 0.82
Biopsy set 3: Western blot (Ctrl = 5, EoE-active = 5, EoE-inactive = 5)
Age Male Female Peak eosinophils per high-power field
Ctrl 10.4 ± 1.2 80% 50% 0 ± 0
EoE-active 10 ± 3.2 80% 20% 42 ± 9.6
EoE-inactive 10 ± 1.8 80% 20% 0 ± 0
Biopsy set 4: DMOG cultures ex vivo (Ctrl = 6, EoE = 6)
Age Male Female Peak eosinophils per high-power field
Ctrl 11.5 ± 2.3 17% 83% 0 ± 0
EoE 10.3 ± 2.7 67% 33% 71.5 ± 27.8
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